logo

Gilead Sciences | Sustainability & Chart

US3755581036

Basic information on Gilead Sciences

Location: United States

Industry: Manufacturing

Website

knob-globe
44%

Impact Score

Description Gilead Sciences

Gilead Sciences is a biopharmaceutical company that focuses on the research, development, and commercialization of medicines in areas such as HIV, liver diseases, and oncology.

Gilead Sciences Sustainability Performance

Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare Gilead Sciences with ...

Gilead Sciences

?

Impact Score

knob-globe
44%
knob-globe
0%
Climate
Society
Gender

Sources of sustainability performance

MetricValueUnitYearPDF NamePDF Page
CEO Pay Ratio
CEO-to-median-salary-ratio119Ratio2025sec-def-14a-2025-remuneration-report.pdf76
CEO nameDaniel P. O’Day2025sec-def-14a-2025-remuneration-report.pdf77
Employee Turnover Rate
Voluntary employee turnover5,3%20252025-impact-report.pdf66
Glass Ceiling
Women on executive board1people2025sec-10-k-2025-annual-report.pdf17
Executive board size5people2025sec-10-k-2025-annual-report.pdf17
Women in workforce52,4%20252025-impact-report.pdf66
Greenhouse Gas Emissions
Scope 2 emissions, location based42 584MT CO2e2025environmental-sustainability-data-performance-tables.pdf3
Scope 1 emissions50 346MT CO2e2025environmental-sustainability-data-performance-tables.pdf3
Number of employees18 157people2025sec-def-14a-2025-remuneration-report.pdf76
Harassment and Discrimination at the Workplace
Confidentiality mechanismsYes2025Code-of-Ethics.pdf28
Incident notification mechanismYes2025Code-of-Ethics.pdf28
Anti-discrimination policyYes2025sec-def-14a-2025-remuneration-report.pdf45
Retaliation safeguardsYes2025Code-of-Ethics.pdf28
Renewable Energy
Total renewable energy consumption190 154MWH2025environmental-sustainability-data-performance-tables.pdf7
Total energy consumption424 797MWH2025environmental-sustainability-data-performance-tables.pdf7
Supply Chain
Number of employees18 157people2025sec-def-14a-2025-remuneration-report.pdf76
Scope 2 emissions, location based42 584MT CO2e2025environmental-sustainability-data-performance-tables.pdf3
Scope 3 emissions1 355 943MT CO2e2025environmental-sustainability-data-performance-tables.pdf5
Scope 1 emissions50 346MT CO2e2025environmental-sustainability-data-performance-tables.pdf3
Union Formation and Collective Bargaining Power
Collective bargaining agreements coverage6%20232023-Environmental-Social-Governance-Impact-Report.pdf113
Recycling and Recovery of Waste
Waste recycled3 159MT2025environmental-sustainability-data-performance-tables.pdf9
Total waste generation9 972MT2025environmental-sustainability-data-performance-tables.pdf9
Women on Board
Executive board size5people2025sec-10-k-2025-annual-report.pdf17
Supervisory board size9people2025sec-10-k-2025-annual-report.pdf17
Women on supervisory board3people2025sec-10-k-2025-annual-report.pdf17
Women on executive board1people2025sec-10-k-2025-annual-report.pdf17
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

logo
© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev